The US public health insurance plan - a bridge too far?
This article was originally published in Scrip
Executive Summary
US healthcare reform has edged a little closer after the Senate voted to go ahead and debate its own consolidated reform bill. But it is looking increasingly likely that one of the central proposals – the controversial government-run public health insurance scheme – may have to be jettisoned, or at least heavily diluted, if the reform is to pass Congress.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.